Indian Journal of Anaesthesia (IJA)
WEEKLY QUIZ #21
IJA Quiz Masters -
Dr. Muralidhar Thondebhavi S,
Dr. Manshad Showkath, Dr. Shilpa GK Bhat, Dr. Bhavna Gupta, Dr. Tushar Chokshi
Dr. Rakesh Garg
Editor-in-Chief
Indian Journal of Anaesthesia
Dr. Rakesh Garg
Editor-in-Chief
Indian Journal of Anaesthesia
Q 1. Most cases of Myocardial Injury after Non Cardiac
Surgery(MINS) ---------
A)Occur in the first 24
hours and has a strong association with hypotension
B) Occur in the first 30
days and has a strong association with sepsis
C) Occur in the first 3 days and has a strong
association with hypotension
D) Occur in the first 3
days and has a strong association with bleeding
Ans C
Upadhyay, Prateek; Hicks, Megan Henley1;
Khanna, Ashish K.2. Enhanced monitoring for postoperative hospital wards –
Evidence to implementation. Indian Journal of Anaesthesia 68(6):p 511-513, June
2024. | DOI: 10.4103/ija.ija_360_24
Q
2. How many episodes of mean arterial pressures below 65 mmHg are missed during
intermittent monitoring?
A) 50 %
B) 60 %
C) 75 %
D) 90 %
The correct answer D
Upadhyay, Prateek; Hicks, Megan Henley1;
Khanna, Ashish K.2. Enhanced monitoring for postoperative hospital wards –
Evidence to implementation. Indian Journal of Anaesthesia 68(6):p 511-513, June
2024. | DOI: 10.4103/ija.ija_360_24
Question
3: international observational study evaluating tracheal intubation
(TI) practice in critically ill patients (INTUBE) reported that ------- % of
critically ill patients develop a major peri-intubation adverse event
A) 45 %
B) 35 %
C) 65 %
D) 63.7 %
Ans A
Khawaja, Asad1;
Karamchandani, Kunal2. Induction agents for emergency airway management in
critically ill patients. Indian Journal of Anaesthesia 68(6):p 514-516, June
2024. | DOI: 10.4103/ija.ija_380_24
Question
4: A sub study of the CORTICUS trial for etomidate found
an increased association with 28 day mortality and a decreased response to
which molecule
A) Cortcotropin
B) Melanotropin
C) Melanocyte
simulating Hormone
D) Pro Opio Melanocortin
(POMC)
Answer: A
Khawaja, Asad1;
Karamchandani, Kunal2. Induction agents for emergency airway management in
critically ill patients. Indian Journal of Anaesthesia 68(6):p 514-516, June
2024. | DOI: 10.4103/ija.ija_380_24
Question
5: What is the incidence range of postoperative neurocognitive
dysfunction (PNCD)
A) 11-30%
B) 25-40%
C) 11-51%
D) 30-50%
Answer: C
https://journals.lww.com/ijaweb/fulltext/2024/06000/effect_of_prophylactic_corticosteroids_on.3.aspx
Singh, Narinder P.; Makkar, Jeetinder K.1; Goel, Nitika1; Karamchandani,
Kunal2; Singh, Mandeep3; Singh, Preet M.4. Effect of prophylactic
corticosteroids on postoperative neurocognitive dysfunction in the adult
population: An updated systematic review, meta-analysis, and trial sequential
analysis of randomised controlled trials. Indian Journal of Anaesthesia 68(6):p
517-526, June 2024. | DOI: 10.4103/ija.ija_149_24
Q6. Which drug is used in the preoperative
period that is reported to attenuate Post operative Neuro Cognitive
dysfunction?
A)
Melatonin
B)
Corticosteroids
C)
Dexmeditomedine
D)
Glycopyrollate
Answer : B
https://journals.lww.com/ijaweb/fulltext/2024/06000/effect_of_prophylactic_corticosteroids_on.3.aspx
Singh, Narinder P.; Makkar, Jeetinder K.1; Goel, Nitika1; Karamchandani,
Kunal2; Singh, Mandeep3; Singh, Preet M.4. Effect of prophylactic
corticosteroids on postoperative neurocognitive dysfunction in the adult
population: An updated systematic review, meta-analysis, and trial sequential
analysis of randomised controlled trials. Indian Journal of Anaesthesia 68(6):p
517-526, June 2024. | DOI: 10.4103/ija.ija_149_24
Q.7 Olanzapine exerts in anti emetic action
through all of the following receptors except
A)
Serotonin.
B)
Dopamine
C)
Acetylcholine
D)
Neurokinin
Answer: D
Deb, Binayak; Saini,
Kulbhushan; Arora, Suman; Kumar, Sanjay; Soni, Shiv L.; Saini, Manu1.
Olanzapine versus standard antiemetic prophylaxis for the prevention of
post-discharge nausea and vomiting after propofol-based general anaesthesia: A
randomised controlled trial. Indian Journal of Anaesthesia 68(6):p 566-571,
June 2024. | DOI: 10.4103/ija.ija_1162_23
Q. 8 Which of the following is NOT one of the
five domains assessed by the updated Cochrane risk-of-bias tool for randomized
trials (ROB2)?
A)
Missing outcome data
B)
Randomisation process
C)
Participant demographics
D)
Deviations from the intended intervention
Answer C
https://journals.lww.com/ijaweb/fulltext/2024/06000/effect_of_prophylactic_corticosteroids_on.3.aspx
Singh, Narinder P.; Makkar, Jeetinder K.1; Goel, Nitika1; Karamchandani,
Kunal2; Singh, Mandeep3; Singh, Preet M.4. Effect of prophylactic
corticosteroids on postoperative neurocognitive dysfunction in the adult
population: An updated systematic review, meta-analysis, and trial sequential
analysis of randomised controlled trials. Indian Journal of Anaesthesia 68(6):p
517-526, June 2024. | DOI: 10.4103/ija.ija_149_24
Q.9 Which of the following
dimensions of health does the Quality of Recovery-40 (QoR-40) score evaluate?
A) Emotional state, physical fitness, social interaction, pain
management
B) Emotional
state, physical comfort, independence, psychological support, pain
C) Physical fitness, mental acuity, social support, emotional well-being
D) Physical comfort, cognitive function, social
integration, pain relief
Answer: B)
Govil, Nishith; Rathore,
Rishika; Tiwari, Ajeet1; Garg, Pankaj K.1; Parag, Kumar; Mishra, Priyanka.
Hindi translation and cultural adaptation of the quality of recovery score-40
(QoR-40 score): A validation study. Indian Journal of Anaesthesia 68(6):p
533-539, June 2024. | DOI: 10.4103/ija.ija_1100_23
Q.10 Which of the following
statements is true regarding the use of dexmedetomidine in patients undergoing
electroconvulsive therapy (ECT)?
A) A high dose of dexmedetomidine is required to reduce myalgia and
fasciculations.
B) Dexmedetomidine has no effect on myalgia and
fasciculations caused by succinylcholine.
C) A low dose
of dexmedetomidine (0.25 µg/kg) effectively reduces myalgia and fasciculations.
D) Dexmedetomidine exacerbates myalgia and fasciculations during ECT.
The correct answer is C)
https://journals.lww.com/ijaweb/fulltext/2024/06000/dexmedetomidine_for_reducing.9.aspx
Sriramka, Bhavna; Panigrahy, Sasmita; Ramasubbu, Mathan Kumar1; Mishra,
Suvendu N.2. Dexmedetomidine for reducing succinylcholine-induced myalgia in
patients undergoing electroconvulsive therapy: A randomised controlled trial.
Indian Journal of Anaesthesia 68(6):p 560-565, June 2024. | DOI:
10.4103/ija.ija_1159_23
No comments:
Post a Comment